Arrowstreet Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
2021
Q1
$280K Sell
2020
Q4
$750K Buy
2020
Q3
Sell
2020
Q2
$663K Buy
2020
Q1
$631K Sell
2019
Q4
$1.63M Buy
2018
Q3
Sell
2018
Q2
$305K Sell
2018
Q1
$440K Sell
2017
Q4
$9.41M Sell
2017
Q3
$12.9M Buy
2017
Q2
$276K Buy